B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin API Manufacturers | Suppliers | Drug Master Files (DMF) | CEP

01

Country

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

APGA Annual Conference

Not Confirmed

02

Novo Nordisk

Denmark

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

APGA Annual Conference

Not Confirmed

03

Hangzhou Jiuyuan Gene Engineering

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

APGA Annual Conference

Not Confirmed

04

Amphastar Pharmaceuticals

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

APGA Annual Conference

Not Confirmed

Looking for 844439-96-9 / Degludec API manufacturers, exporters & distributors?

PharmaCompass offers a list of Degludec API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Degludec manufacturer or Degludec supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Degludec manufacturer or Degludec supplier.

PharmaCompass also assists you with knowing the Degludec API Price utilized in the formulation of products. Degludec API Price is not always fixed or binding as the Degludec Price is obtained through a variety of data sources. The Degludec Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Degludec

Synonyms

844439-96-9, Tresiba, Insulin degludec [usan:inn], Unii-54q18076qb, Nn 1250, Nn1250

Cas Number

844439-96-9

About Degludec

Insulin Degludec is a recombinant, long-acting analog of human insulin, with blood glucose-lowering activity. Upon subcutaneous injection, insulin degludec forms a multi-hexameric depot from which insulin monomers are slowly released into the systemic circulation. Insulin regulates glucose metabolism by binding to insulin receptors on muscle and fat cells, which stimulates the cellular uptake of glucose and lowers blood glucose levels. Insulin inhibits the liver's conversion of stored glycogen into glucose, which also contributes to lower blood glucose levels. In addition, insulin inhibits lipolysis in adipose tissue, inhibits proteolysis, and enhances protein synthesis. Insulin degludec doesn't contain the amino acid threonine that is found at position B30 in human insulin; additionally, the lysine at position B29 is conjugated to hexadecanedioic acid, which allows the formation of the multi-hexamers upon subcutaneous injection. The phenol and zinc present in the pharmaceutical formulation promote a di-hexameric state of insulin degludec.

B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin Manufacturers

A B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin, including repackagers and relabelers. The FDA regulates B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin Suppliers

A B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin supplier is an individual or a company that provides B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin active pharmaceutical ingredient (API) or B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin finished formulations upon request. The B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin suppliers may include B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin API manufacturers, exporters, distributors and traders.

click here to find a list of B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin Manufacturers | Traders | Suppliers

We have 3 companies offering B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin

Get in contact with the supplier of your choice:

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.